| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |